×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Fabrice Lécuru & Gwenaël Ferron

Au programme de cette soirée

18:00 Introduction
Gwenaël Ferron
 
18:05 Il y a-t-il encore une place pour la chirurgie minimale invasive dans le cancer de l'ovaire ?
  • Débutant, Eric Lambaudie
  • Avancé, Christophe Pomel
18:25 Curages ganglionnaires dans les stades précoces
Enora Laas Faron
 
18:45 Faut-il faire une chirurgie différente en fonction du statut BRCA-HR ?
Fabrice Lécuru
 
19:05 Place de l’intensification intra-péritonéale
Pierre-Emmanuel Colombo
 
19:25 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2022-10-18
Last update : 2022-11-28

Suggestions

Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Monday, October 16th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Monday, October 16th 2023 from 09am to 10:30am (GMT+2)
New York : Monday, October 16th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Monday, October 16th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Monday, October 16th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Monday, October 16th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Monday, October 16th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+2)
Sydney : Tuesday, October 17th 2023 from 03am to 04:30am (GMT+2)
Wellington : Tuesday, October 17th 2023 from 05am to 06:30am (GMT+2)

La nouvelle classification des cancers de l’endomètre en pratique

Cycle d'enseignement - Les cancers gynécologiques

Share
Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, January 31st 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, January 31st 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, January 31st 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, January 31st 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, January 31st 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, January 31st 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, January 31st 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 1st 2024 from 04am to 05:30am (GMT+1)

KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

Share
Scroll Up